Similar articles

• Emily Cooley Memorial Award. Managing change to improve transfusion safety.

  AuBuchon JP. AuBuchon JP. Transfusion. 2004 Sep;44(9):1377-83. doi: 10.1111/j.0041-1132.2004.04183.x. Transfusion. 2004. PMID: 15318865 No abstract available.
• Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.

  Dean CL, Wade J, Roback JD. Dean CL, et al. J Clin Microbiol. 2018 Jun 25;56(7):e00352-18. doi: 10.1128/JCM.00352-18. Print 2018 Jul. J Clin Microbiol. 2018. PMID: 29669792 Free PMC article. Review.
• Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.

  Brooks JP. Brooks JP. Transfusion. 2005 Oct;45(4 Suppl):159S-71S. doi: 10.1111/j.1537-2995.2005.00617.x. Transfusion. 2005. PMID: 16181401 Review.
• FDA approach to evaluation of pathogen reduction technology.

  Epstein JS, Vostal JG. Epstein JS, et al. Transfusion. 2003 Oct;43(10):1347-50. doi: 10.1046/j.1537-2995.2003.00584.x. Transfusion. 2003. PMID: 14507263 No abstract available.
• Evolution of microbial safety.

  Barbara JA. Barbara JA. Hematol J. 2004;5 Suppl 3:S69-73. doi: 10.1038/sj.thj.6200426. Hematol J. 2004. PMID: 15190282 Review. No abstract available.